EXELIXIS INC. DL-,01 |
USA |
Gesundheit |
US30161Q1040 / 936718 |
EX9 (Frankfurt) / EXEL (NASDAQ) |
FRA:EX9, ETR:EX9, EX9:GR, NASDAQ:EXEL |
- |
https://www.exelixis.com/ |
10591.06 Mio. EUR |
1957.95 Mio. EUR |
719.06 Mio. EUR |
1.92 EUR |
159.37 Mio. EUR |
101.18 Mio. EUR |
24.16% / 213.03% |
19.11 / 17.36 |
5.62 / 5.44 / 0.08 |
27.99% / 30.22% |
- |
- / - |
- |
EXELIXIS |
26.07.25 |